How has Rapid Micro Biosystems's capitalized software licenses changed year-over-year?

Rapid Micro Biosystems's capitalized software licenses decreased by 0.0% year-over-year, from $1.6M to $1.6M.

What is the long-term trend for Rapid Micro Biosystems's capitalized software licenses?

Over 2 years (2023 to 2025), Rapid Micro Biosystems's capitalized software licenses has grown at a 6.9% compound annual growth rate (CAGR), from $1.4M to $1.6M.

Rapid Micro Biosystems RPID Capitalized software licenses

Capitalized software licenses at other companies

Simulations PlusSLP

——

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedComputerSoftwareNet.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's capitalized software licenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's capitalized software licenses?: Rapid Micro Biosystems (RPID) reported capitalized software licenses of $1.6M in Q1 2026.
How has Rapid Micro Biosystems's capitalized software licenses changed year-over-year?: Rapid Micro Biosystems's capitalized software licenses decreased by 0.0% year-over-year, from $1.6M to $1.6M.
What is the long-term trend for Rapid Micro Biosystems's capitalized software licenses?: Over 2 years (2023 to 2025), Rapid Micro Biosystems's capitalized software licenses has grown at a 6.9% compound annual growth rate (CAGR), from $1.4M to $1.6M.